The effect of statins on high-risk atherosclerotic plaque associated with low endothelial shear stress

Current Opinion in Lipidology

Volumn 22, Issue 5, 2011, Pages 358-364

  Takahashi, Saeko ^a   Papafaklis, Michail I ^a   Sakamoto, Shingo ^a   Antoniadis, Antonios P ^a   Coskun, Ahmet U ^a   Feldman, Charles L ^b   Stone, Peter H ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Northeastern University   (United States)

Author keywords

endothelial shear stress; high risk plaque; LDL cholesterol; statins; thin cap fibroatheromas

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; CATHEPSIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FLUINDOSTATIN; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; KRUPPEL LIKE FACTOR 2; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVALONIC ACID; PLACEBO; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN; VALSARTAN;

ARTERY WALL; ATHEROMA; ATHEROSCLEROTIC PLAQUE; BLOOD FLOW VELOCITY; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFECT; ENDOTHELIAL SHEAR STRESS; ENDOTHELIUM; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; IMMUNOREACTIVITY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SHEAR STRESS;

ANIMALS; ATHEROSCLEROSIS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PLAQUE, ATHEROSCLEROTIC; STRESS, MECHANICAL;

EID: 80052740633     PISSN: 09579672     EISSN: 14736535     Source Type: Journal    
DOI: 10.1097/MOL.0b013e32834ab106     Document Type: Review

References (53)

1. Baigent C, Keech A, Kearney PM, et al. Efficacy and safety of cholesterollowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins. Lancet 2005; 366:1267-1278.
2. Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004; 350:1495-1504. (Pubitemid 38477774)
3. Ray KK, Seshasai SR, Erqou S, et al. Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65 229 participants. Arch Intern Med 2010; 170:1024-1031.
4. Virmani R, Kolodgie FD, Burke AP, et al. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000; 20:1262-1275. (Pubitemid 30262927)
5. Chatzizisis YS, Coskun AU, Jonas M, et al. Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cellular, and vascular behavior. J Am Coll Cardiol 2007; 49: 2379-2393. (Pubitemid 46962266)
6. Asakura T, Karino T. Flow patterns and spatial distribution of atherosclerotic lesions in human coronary arteries. Circ Res 1990; 66:1045-1066. (Pubitemid 20126435)
7. Gibson CM, Diaz L, Kandarpa K, et al. Relation of vessel wall shear stress to atherosclerosis progression in human coronary arteries. Arterioscler Thromb 1993; 13:310-315. (Pubitemid 23056805)
8. Stone PH, Coskun AU, Kinlay S, et al. Effect of endothelial shear stress on the progression of coronary artery disease, vascular remodeling, and in-stent restenosis in humans: in vivo 6-month follow-up study. Circulation 2003; 108:438-444. (Pubitemid 36935537)
9. Cheng C, Tempel D, van Haperen R, et al. Atherosclerotic lesion size and vulnerability are determined by patterns of fluid shear stress. Circulation 2006; 113:2744-2753. (Pubitemid 43947992)
10. Koskinas KC, Feldman CL, Chatzizisis YS, et al. Natural history of experimental coronary atherosclerosis and vascular remodeling in relation to endothelial shear stress: a serial, in vivo intravascular ultrasound study. Circulation 2010; 121:2092-2101.
11. Papafaklis MI, Koskinas KC, Baker AB, et al. Low endothelial shear stress upregulates atherogenic and inflammatory genes extremely early in the natural history of coronary artery disease in diabetic hyperlipidemic juvenile swine [abstract]. Eur Heart J 2011 (in press).
12. Chatzizisis YS, Baker AB, Sukhova GK, et al. Augmented expression and activity of extracellular matrix-degrading enzymes in regions of low endothelial shear stress colocalize with coronary atheromata with thin fibrous caps in pigs. Circulation 2011; 123:621-630.
13. Chatzizisis YS, Jonas M, Coskun AU, et al. Prediction of the localization of high-risk coronary atherosclerotic plaques on the basis of low endothelial shear stress: an intravascular ultrasound and histopathology natural history study. Circulation 2008; 117:993-1002.
14. Brunner S, Kim J-O, Methe H. Relation of matrix metalloproteinase-9/ tissue inhibitor of metalloproteinase-1 ratio in peripheral circulating CD14\+ monocytes to progression of coronary artery disease. Am J Cardiol 2010; 105:429-434.
15. Libby P. The molecular mechanisms of the thrombotic complications of atherosclerosis. J Intern Med 2008; 263:517-527. (Pubitemid 351533560)
16. Dollery CM, Libby P. Atherosclerosis and proteinase activation. Cardiovasc Res 2006; 69:625-635. (Pubitemid 43139725)
17. Gambillara V, Montorzi G, Haziza-Pigeon C, et al. Arterial wall response to ex vivo exposure to oscillatory shear stress. J Vasc Res 2005; 42:535-544. (Pubitemid 41527609)
18. Platt MO, Ankeny RF, Shi GP, et al. Expression of cathepsin K is regulated by shear stress in cultured endothelial cells and is increased in endothelium in human atherosclerosis. Am J Physiol Heart Circ Physiol 2007; 292:H1479-H1486. (Pubitemid 46377136)
19. Sun HW, Li CJ, Chen HQ, et al. Involvement of integrins, MAPK, and NFkappaB in regulation of the shear stress-induced MMP-9 expression in endothelial cells. Biochem Biophys Res Commun 2007; 353:152-158.
20. Sukhova GK, Shi GP, Simon DI, et al. Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J Clin Invest 1998; 102:576-583. (Pubitemid 28376160)
21. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362:801-809. (Pubitemid 23132154)
22. Ross R. Genetically modified mice as models of transplant atherosclerosis. Nat Med 1996; 2:527-528. (Pubitemid 26150679)
23. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340:115-126.
24. Koskinas KC, Papafaklis MI, Baker AB, et al. Pronounced smooth muscle cell apoptosis in coronary regions of low endothelial shear stress co-localizes with features of atherosclerotic plaque vulnerability. A natural history study in diabetic, hypercholesterolemic pigs [abstract]. Arterioscler Thromb Vasc Biol 2011. (in press).
25. Fukumoto Y, Libby P, Rabkin E, et al. Statins alter smooth muscle cell accumulation and collagen content in established atheroma of watanabe heritable hyperlipidemic rabbits. Circulation 2001; 103:993-999. (Pubitemid 32183806)
26. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344:1383-1389.
27. Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med 1996; 335:1001-1009. (Pubitemid 26338729)
28. Kaneda H, Ako J, Terashima M. Intravascular ultrasound imaging for assessing regression and progression in coronary artery disease. Am J Cardiol 2010; 106:1735-1746.
29. Nissen SE, Tuzcu EM, Schoenhagen P, et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 2004; 291:1071-1080. (Pubitemid 38541684)
30. Aikawa M, Rabkin E, Okada Y, et al. Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization. Circulation 1998; 97:2433-2444. (Pubitemid 28278188)
31. Aikawa M, Rabkin E, Voglic SJ, et al. Lipid lowering promotes accumulation of mature smooth muscle cells expressing smooth muscle myosin heavy chain isoforms in rabbit atheroma. Circ Res 1998; 83:1015-1026. (Pubitemid 28520931)
32. Aikawa M, Voglic SJ, Sugiyama S, et al. Dietary lipid lowering reduces tissue factor expression in rabbit atheroma. Circulation 1999; 100:1215-1222. (Pubitemid 29426598)
33. Werner N, Nickenig G, Laufs U. Pleiotropic effects of HMG-CoA reductase inhibitors. Basic Res Cardiol 2002; 97:105-116. (Pubitemid 34223500)
34. Libby P, Aikawa M. Mechanisms of plaque stabilization with statins. Am J Cardiol 2003; 91:4B-8B. (Pubitemid 36263242)
35. Akdim F, van Leuven SI, Kastelein JJ, et al. Pleiotropic effects of statins: stabilization of the vulnerable atherosclerotic plaque? Curr Pharm Des 2007; 13:1003-1012. (Pubitemid 46696556)
36. Ridker PM. Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design of the JUPITER trial. Circulation 2003; 108:2292-2297. (Pubitemid 37413531)
37. Aikawa M, Rabkin E, Sugiyama S, et al. An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro. Circulation 2001; 103:276-283. (Pubitemid 32095415)
38. Rosenson RS, Tangney CC, Casey LC. Inhibition of proinflammatory cytokine production by pravastatin. Lancet 1999; 353:983-984. (Pubitemid 29132615)
39. Shiomi M, Ito T, Tsukada T, et al. Reduction of serum cholesterol levels alters lesional composition of atherosclerotic plaques. Effect of pravastatin sodium on atherosclerosis in mature WHHL rabbits. Arterioscler Thromb Vasc Biol 1995; 15:1938-1944.
40. Crisby M, Nordin-Fredriksson G, Shah PK, et al. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization. Circulation 2001; 103:926-933. (Pubitemid 32183796)
41. Stone GW, Maehara A, Lansky AJ, et al. A prospective natural-history study of coronary atherosclerosis. N Engl J Med 2011; 364:226-235.
42. Takarada S, Imanishi T, Kubo T, et al. Effect of statin therapy on coronary fibrous-cap thickness in patients with acute coronary syndrome: assessment by optical coherence tomography study. Atherosclerosis 2009; 202:491-497.
43. Wada S, Karino T. Theoretical study on flow-dependent concentration polarization of low density lipoproteins at the luminal surface of a straight artery. Biorheology 1999; 36:207-223. (Pubitemid 29518693)
44. Wada S, Koujiya M, Karino T. Theoretical study of the effect of local flow disturbances on the concentration of low-density lipoproteins at the luminal surface of end-to-end anastomosed vessels. Med Biol Eng Comput 2002; 40:576-587. (Pubitemid 35356073)
45. Wada S, Karino T. Theoretical prediction of low-density lipoproteins concentration at the luminal surface of an artery with a multiple bend. Ann Biomed Eng 2002; 30:778-791. (Pubitemid 35019465)
46. Soulis JV, Fytanidis DK, Papaioannou VC, et al. Wall shear stress on LDL accumulation in human RCAs. Med Eng Phys 2010; 32:867-877.
47. Soulis JV, Giannoglou GD, Chatzizisis YS, et al. Non-Newtonian models for molecular viscosity and wall shear stress in a 3D reconstructed human left coronary artery. Med Eng Phys 2008; 30:9-19.
48. Chatzizisis YS, Jonas M, Beigel R, et al. Attenuation of inflammation and expansive remodeling by valsartan alone or in combination with simvastatin in high-risk coronary atherosclerotic plaques. Atherosclerosis 2009; 203:387-394.
49. Box FM, van der Grond J, de Craen AJ, et al. Pravastatin decreases wall shear stress and blood velocity in the internal carotid artery without affecting flow volume: results from the PROSPER MRI study. Stroke 2007; 38:1374-1376. (Pubitemid 351664276)
50. LaDisa JF Jr, Bowers M, Harmann L, et al. Time-efficient patient-specific quantification of regional carotid artery fluid dynamics and spatial correlation with plaque burden. Med Phys 2010; 37:784-792.
51. Wentzel JJ, Corti R, Fayad ZA, et al. Does shear stress modulate both plaque progression and regression in the thoracic aorta? Human study using serial magnetic resonance imaging. J Am Coll Cardiol 2005; 45:846-854. (Pubitemid 40342807)
52. Rossi J, Rouleau L, Tardif JC, et al. Effect of simvastatin on Kruppel-like factor2, endothelial nitric oxide synthase and thrombomodulin expression in endothelial cells under shear stress. Life Sci 2010; 87:92-99.
53. Rossi J, Jonak P, Rouleau L, et al. Differential response of endothelial cells to simvastatin when conditioned with steady, nonreversing pulsatile or oscillating shear stress. Ann Biomed Eng 2011; 39:402-413.